Marijuana Company of America, Inc. (OTC Pink: MCOA), announced this morning that the company’s wholly owned subsidiary hempSMART™, a hemp derived CBD product development and distribution company, has relaunched its flagship botanical supplement product hempSMART™ Brain that contains 10mg of Cannabidiol (CBD) oil per serving.
The company’s product hempSMART™ Brain has been relaunched and redesigned with an improved formulation that contains 300mg per bottle of Full Spectrum, non-psychoactive, water soluble CBD oil and contains a botanical blend of all-natural plant-based ingredients such as Ashwaganda, Fulvic Acid, Rhodiola Rosea Extract, Bacopa, L-Theanine, Green Tea Extract, and Huperzia Serrata.
hempSMART has developed its Brain product to provide customers with mental clarity, alertness, focus and concentration as well as promote relaxation, restorative sleep, and support the repair and regeneration of brain cells, better known as neurogenesis. This unique formula promises to revolutionize the safe, effective, and natural optimization of brain wellness.
hempSMART also sells a number of other products with unique plant based formulas such as hempSMART Pain & Pain Cream, hempSMART Full Spectrum Drops, and hempSMART Full Spectrum Pet Drops.
MCOA’s CEO Donald Steinberg gave this statement in the press release:
,”After reviewing our hempSMART Brain product, our formulators chose to improve upon the original product by doubling the original dosage of CBD. Our team is proud to be able to welcome our flagship product back onto the market and look forward to the upcoming marketing campaigns.”
You may be interested
Aurora Cannabis Provides Investors Updates on their International OperationsEditor - August 13, 2018
Aurora Cannabis (TSX: ACB) (OTCQB: ACBFF) announced this morning a company update on their multiple cannabis related operations around the world. The company has undertaken projects in numerous…
Australians Overwhelmingly Support Medical CannabisEditor - August 13, 2018
Ninety one percent of Australians support medicinal cannabis use. Chronic diseases like epilepsy, chronic pain, nausea in cancer related chemotherapy, multiple sclerosis, PTSD, and palliative care are…
Health Canada Issues Significant Changes to Industrial Hemp RegulationsEditor - August 11, 2018
Health Canada, the overseeing body in charge of industrial hemp licensing and its regulations has just issued a new class exemption for cultivators of the plant within…